- Home
- BZ vs VRNA Comparison
BZ vs VRNA Comparison
Compare BZ & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZ
- VRNA
- Stock Information
- Founded
- BZ 2013
- VRNA 2005
- Country
- BZ China
- VRNA United Kingdom
- Employees
- BZ N/A
- VRNA N/A
- Industry
- BZ Computer Software: Programming Data Processing
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- BZ Technology
- VRNA Health Care
- Exchange
- BZ Nasdaq
- VRNA Nasdaq
- Market Cap
- BZ 9.7B
- VRNA 8.3B
- IPO Year
- BZ 2021
- VRNA 2017
- Fundamental
- Price
- BZ $24.01
- VRNA $106.24
- Analyst Decision
- BZ Strong Buy
- VRNA Buy
- Analyst Count
- BZ 5
- VRNA 11
- Target Price
- BZ $21.20
- VRNA $114.10
- AVG Volume (30 Days)
- BZ 4.8M
- VRNA 1.3M
- Earning Date
- BZ 08-20-2025
- VRNA 11-03-2025
- Dividend Yield
- BZ 0.70%
- VRNA N/A
- EPS Growth
- BZ 51.73
- VRNA N/A
- EPS
- BZ 0.66
- VRNA N/A
- Revenue
- BZ $1,083,348,363.00
- VRNA $221,673,000.00
- Revenue This Year
- BZ $15.19
- VRNA $896.59
- Revenue Next Year
- BZ $13.25
- VRNA $77.56
- P/E Ratio
- BZ $36.32
- VRNA N/A
- Revenue Growth
- BZ 14.01
- VRNA N/A
- 52 Week Low
- BZ $11.81
- VRNA $24.50
- 52 Week High
- BZ $24.34
- VRNA $106.20
- Technical
- Relative Strength Index (RSI)
- BZ 70.60
- VRNA 71.68
- Support Level
- BZ $22.85
- VRNA $105.23
- Resistance Level
- BZ $24.34
- VRNA $105.85
- Average True Range (ATR)
- BZ 0.81
- VRNA 0.28
- MACD
- BZ 0.09
- VRNA -0.24
- Stochastic Oscillator
- BZ 92.00
- VRNA 97.17
About BZ KANZHUN LIMITED American Depository Shares
Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on average number of monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.